ZA949567B - Chewable taste masked complexes containing pharmaceuticals - Google Patents

Chewable taste masked complexes containing pharmaceuticals

Info

Publication number
ZA949567B
ZA949567B ZA949567A ZA949567A ZA949567B ZA 949567 B ZA949567 B ZA 949567B ZA 949567 A ZA949567 A ZA 949567A ZA 949567 A ZA949567 A ZA 949567A ZA 949567 B ZA949567 B ZA 949567B
Authority
ZA
South Africa
Prior art keywords
complexes containing
taste masked
containing pharmaceuticals
chewable taste
masked complexes
Prior art date
Application number
ZA949567A
Other languages
English (en)
Inventor
Franco Francese
Massimo Maneschi
Diego Oldani
Tiziana Crolla
Original Assignee
Smithkline Beecham Farma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Farma filed Critical Smithkline Beecham Farma
Publication of ZA949567B publication Critical patent/ZA949567B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6943—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a pill, a tablet, a lozenge or a capsule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA949567A 1993-12-03 1994-12-01 Chewable taste masked complexes containing pharmaceuticals ZA949567B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI932540A IT1274241B (it) 1993-12-03 1993-12-03 Complessi agente terapeutico/matrice polimerica dotati di migliorate caratteristiche di sapore e composizioni farmaceutiche che li contengono

Publications (1)

Publication Number Publication Date
ZA949567B true ZA949567B (en) 1995-10-10

Family

ID=11367288

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA949567A ZA949567B (en) 1993-12-03 1994-12-01 Chewable taste masked complexes containing pharmaceuticals

Country Status (9)

Country Link
EP (1) EP0804168A1 (ja)
JP (1) JPH09505818A (ja)
CN (1) CN1145586A (ja)
AU (1) AU693144B2 (ja)
CA (1) CA2177721A1 (ja)
IT (1) IT1274241B (ja)
NZ (1) NZ277238A (ja)
WO (1) WO1995015155A1 (ja)
ZA (1) ZA949567B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AU748804B2 (en) * 1995-07-20 2002-06-13 Smithkline Beecham Plc Paroxetine controlled release compositions
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
US5965555A (en) * 1996-06-07 1999-10-12 Hoechst Aktiengesellschaft Xanthine compounds having terminally animated alkynol side chains
DE19631084A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EE03970B1 (et) 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
NZ505123A (en) * 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof
IT1298732B1 (it) * 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
AU3810100A (en) 1999-03-12 2000-10-04 Basf Aktiengesellschaft Stable pharmaceutical application form for paroxetin anhydrate
GB0119467D0 (en) * 2001-08-09 2001-10-03 Smithkline Beecham Plc Novel compound
ES2261726T3 (es) * 2001-08-09 2006-11-16 Smithkline Beecham Plc Composicion que comprende paroxetina y una sal glicirricinato farmaceuticamente aceptable.
PT2802311T (pt) * 2011-10-25 2019-03-19 Expermed S A Composição farmacêutica sublingual contendo um agente anti-histamínico e método para a sua preparação

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ217326A (en) * 1985-08-26 1990-02-26 Searle & Co A porous, active drug-polymer matrix having masked taste properties, wherein the active drug contains amine or amido groups

Also Published As

Publication number Publication date
EP0804168A1 (en) 1997-11-05
WO1995015155A1 (en) 1995-06-08
JPH09505818A (ja) 1997-06-10
NZ277238A (en) 1998-04-27
ITMI932540A0 (it) 1993-12-03
AU1219895A (en) 1995-06-19
CN1145586A (zh) 1997-03-19
AU693144B2 (en) 1998-06-25
IT1274241B (it) 1997-07-15
ITMI932540A1 (it) 1995-06-03
CA2177721A1 (en) 1995-06-08

Similar Documents

Publication Publication Date Title
AP9300494A0 (en) Pharmaceuticals
ZA949567B (en) Chewable taste masked complexes containing pharmaceuticals
GB9221468D0 (en) Pharmaceuticals
GB9204565D0 (en) Pharmaceuticals
GB9219163D0 (en) Pharmaceuticals
GB9205917D0 (en) Pharmaceuticals
GB9214184D0 (en) Pharmaceuticals
GB9201961D0 (en) Pharmaceuticals
GB9220585D0 (en) Pharmaceuticals
GB9208321D0 (en) Pharmaceuticals
GB9205363D0 (en) Pharmaceuticals
GB9213708D0 (en) Pharmaceuticals
GB9218846D0 (en) Pharmaceuticals
GB9223134D0 (en) Pharmaceuticals
GB9211072D0 (en) Pharmaceuticals
GB9207820D0 (en) Pharmaceuticals
GB9207414D0 (en) Pharmaceuticals
GB9222848D0 (en) Pharmaceuticals
GB9205918D0 (en) Pharmaceuticals
GB9211925D0 (en) Pharmaceuticals
GB9205428D0 (en) Pharmaceuticals
GB9205427D0 (en) Pharmaceuticals
GB9205365D0 (en) Pharmaceuticals
GB9223135D0 (en) Pharmaceuticals
GB9223136D0 (en) Pharmaceuticals